Select Your Region
- Manufacturer: Evonik Corporation
- Product Line: LACTEL® Polymers
- Product: LACTEL® PLGA Polymers
- Industries: Pharmaceuticals
- Authorized Countries: Canada | United States
LACTEL 75:25 DL-PLGA, IV 0.70-0.90
LACTEL® 75:25 DL-PLGA, IV 0.70-0.90 is an acid-terminated polymeric drug delivery material made up of a 75:25 ratio of D,L-lactide and glycolide. It has a degradation rate of 3 months and an inherent viscosity of 0.70─0.90 dL/g in chloroform.
Documents
Specifications
Physical state: Solid
Form: Granules or pellets
Color: White to yellowish, off-white to light tan
Inherent viscosity (IV) dL/g: 0.70─0.90 (in chloroform)
Degradation time: <6 months
Density (g/mL): 1.34
Tensile Strength (psi): 6000─8000
Elongation (%): 3─10
Modulus (psi): 2─4x10⁵
CAS no. 26780-50-7
Primary Chemistry:
Poly(DL-lactide-co-glycolide)
- Manufacturer: Evonik Corporation
- Product Line: LACTEL® Polymers
- Product: LACTEL® PLGA Polymers
- Industries: Pharmaceuticals
- Authorized Countries: Canada | United States
Manufacturer
Product Line
Product
Industries
Authorized Countries
Canada
United States
Overview
LACTEL® 75:25 DL-PLGA, IV 0.70-0.90 is a biodegradable and biocompatible synthetic copolymer with a composition of 75 mol % D,L-lactide and 25 mol % Glycolide with an acid end group. Properties such as the inherent viscosity of 0.70─0.90 dL/g in chloroform and degradation rate of 6 months have been optimized to fit the need of a specific release system with optimal metabolization in the body. LACTEL® 75:25 DL-PLGA, IV 0.70-0.90 can be used to release a wide range of small molecule drugs, peptides, and proteins in veterinary medicine and human generic drug formulations providing controlled drug delivery capabilities.
Specifications
Physical state: Solid
Form: Granules or pellets
Color: White to yellowish, off-white to light tan
Inherent viscosity (IV) dL/g: 0.70─0.90 (in chloroform)
Degradation time: <6 months
Density (g/mL): 1.34
Tensile Strength (psi): 6000─8000
Elongation (%): 3─10
Modulus (psi): 2─4x10⁵
CAS no. 26780-50-7
Primary Chemistry:
Poly(DL-lactide-co-glycolide)
Features & Benefits
- 75:25 ratio of D,L-Lactide and Glycolide
- Acid end group
- No added preservatives
- Non-GMO
- Amorphous
- 6 month degradation period
- Bioabsorbable excipient
- Suitable for use with small molecules, peptides, proteins, and other substances
- Unpurified
- Cost-effective
- Non-GMO
Applications
Human generic drug formulations
Long-acting injectable formulations
Price sensitive applications
veterinary medicine
Related Applications
Pharmaceuticals
Related Functions
Pharmaceuticals
ChemPoint is here to help
Are you in the correct region?
We’ve detected that you are located in a different region than the region selected on the website. Would you like to change your region?
Current Region: English - United States
